Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
about
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansGalectin-Binding O-Glycosylations as Regulators of MalignancyAnti-cancer activities of pH- or heat-modified pectinNuclear transport of galectin-3 and its therapeutic implicationsMetabolic methanol: molecular pathways and physiological rolesHuman galectin-2 interacts with carbohydrates and peptides non-classically: new insight from X-ray crystallography and hemagglutinationMethanol may function as a cross-kingdom signalGalectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo StudyModified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injuryActivation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin.Degradation of different pectins by fungi: correlations and contrasts between the pectinolytic enzyme sets identified in genomes and the growth on pectins of different origin.Galectin-3: a potential target for cancer prevention.Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function.Pectin matrix as oral drug delivery vehicle for colon cancer treatmentGalectins in hematological malignancies.Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling.Galectin-3 as a Potential Target to Prevent Cancer Metastasis.Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction.Roles of pectin in biomass yield and processing for biofuels.Chemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells.Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and GalactomannansElevated galectin-3 precedes the development of CKDThe inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.The role of galectins in colorectal cancer progression.Atomic force microscopy as a nanoscience tool in rational food design.The sweet side of tumor immunotherapy.Galectin-3 inhibitors: a patent review (2008-present).Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells.Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.Comparative studies on the anti-tumor activities of high temperature- and pH-modified citrus pectins.Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines.PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and- independent prostate cancer cells.The N-terminal tail coordinates with carbohydrate recognition domain to mediate galectin-3 induced apoptosis in T cells.Physicochemical properties of modified citrus pectins extracted from orange pomace.Faba bean hulls as a potential source of pectin.Galectin-3 and new-onset CKD: marker or mediator?
P2860
Q24308236-E3A19E64-4695-474E-91E6-DE2EB62F6EB6Q26801724-8803D277-D2F8-4D8C-80D7-AE50AE22D379Q26821932-A8C6C9AC-AFC4-40BD-8A21-8D9BBAEE76F0Q26824889-603FF5AF-82AD-41AE-A6DF-DEC99A7F70D6Q27000276-575B7516-2665-4B4B-BC13-9EE9392DED47Q27727738-8CF13FB3-F25E-4D5F-9FE6-492D40406B1FQ28482670-F328F4D0-FCD5-49C8-928A-0B27DBA66B65Q33577541-1E49AF48-BC32-468E-94D1-05AF1E31DDA2Q33873592-11CED157-6830-44B2-A4E3-47ED839009F8Q33982118-1539F077-08D4-4B78-AC95-F1576D986B86Q34343738-CD84679E-5D1C-4C99-B377-6313A3C58C36Q34626339-7D7A6FE3-0DAF-42D4-9418-323F7452A94EQ34676070-18C44101-330B-4EA1-B84B-3DFA393D226DQ34733868-33B3A727-F5B1-4626-847A-338EFD58EC01Q35824985-0E67C47E-3B2A-41B8-BC60-67BBC375FC37Q36260595-F14CB0DE-B7EE-4C20-A919-66A0B125F4F3Q36326176-06F7CA6C-825B-41CD-ACCB-09CD3E3DCA70Q36414261-1FFEF784-ACF5-4CC7-A351-7D884D480C6DQ36439679-11B8D5CD-E3ED-4625-BAE6-412F2CD08F0AQ36627699-D4CF1D21-B45C-4CC5-9C89-453E0E3A2B46Q36718529-F0B0FA62-ED84-47CE-B106-87B75043F838Q36911100-941852C5-A67F-4ED7-B8C9-E200D0654836Q37065931-86950A3A-CA46-4BD6-B6DE-3260E04D4AB9Q37119904-CC387D91-D342-4707-B494-E515C8B873FAQ37333778-6B6265BE-104F-4B14-B586-33AB767FC6C4Q37869015-AE692FF3-5FFD-4299-87D3-A421FDE7ECE8Q37902611-0B41CD3C-6227-48D8-A468-727415399BFCQ38031282-6043C922-1421-429D-B4A0-BE807EA5FC7AQ38238525-FCEEE100-42AB-4EBA-8FFA-7DB4871BB6AFQ38306237-004A7B89-E56A-4431-BC8F-CD62576B3442Q38721483-76892277-2376-4693-83CE-2FBE919ACA20Q39152161-826BE842-2CDA-45F7-A98F-4DF3A99D9C8CQ39191329-9B36AE16-6381-49AC-809B-29C2E9665EFFQ39359190-384641C2-C96D-4174-ACF2-66F5B23890EEQ39418336-F2354539-EDBE-4966-82A2-90FA3A1D109AQ39704679-13F72615-7C04-4B37-84E4-4CE70254E42FQ41472767-533ED8BB-3D01-482A-8C06-9E9FFEC8AC63Q41572263-4D295379-3EA7-43B6-8EE7-924EFD7D91EFQ42181817-044491AD-D3B1-468F-AD12-4CCD6A2392A9Q42569059-11D5394B-E19A-4C36-A7D2-3BA03D0CCB53
P2860
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@ast
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@en
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@nl
type
label
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@ast
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@en
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@nl
prefLabel
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@ast
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@en
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@nl
P2860
P3181
P1476
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
@en
P2093
Avraham Raz
Vladislav V Glinsky
P2860
P304
P3181
P356
10.1016/J.CARRES.2008.08.038
P407
P577
2009-09-28T00:00:00Z